Results 91 to 100 of about 5,218,351 (211)

Generation and Characterization of a Bivalent HIV-1 Subtype C gp120 Protein Boost for Proof-of-Concept HIV Vaccine Efficacy Trials in Southern Africa.

open access: yesPLoS ONE, 2016
The viral envelope glycoprotein (Env) is the major target for antibody (Ab)-mediated vaccine development against the Human Immunodeficiency Virus type 1 (HIV-1).
Carlo Zambonelli   +14 more
doaj   +1 more source

Discontinuous sequence change of human immunodeficiency virus (HIV) type 1 env sequences in plasma viral and lymphocyte-associated proviral populations in vivo:implications for models of HIV pathogenesis [PDF]

open access: yes, 1991
Sequence change in different hypervariable regions of the external membrane glycoprotein (gp120) of human immunodeficiency virus type 1 (HIV-1) was studied.
Zhang, L Q   +5 more
core  

Mapping Reactivities of Murine Monoclonal Antibodies to the External Envelope Glycoprotein (gp120) of Human Immunodeficiency Virus Type 1 (HIV-1)

open access: yes, 1990
A group of monoclonal antibodies generated from the envelope glycoprotein (gp120) of human immunodeficiency virus type 1B (HIV-1B) or type 1RF (HIV-1RF) were selected for characterization and epitope mapping studies.
Johnson, Donald Gibson
core   +1 more source

Surfactant Protein D modulates HIV infection of both T-cells and dendritic cells.

open access: yesPLoS ONE, 2013
Surfactant Protein D (SP-D) is an oligomerized C-type lectin molecule with immunomodulatory properties and involvement in lung surfactant homeostasis in the respiratory tract.
Jens Madsen   +5 more
doaj   +1 more source

Quercetin ameliorates HIV-1 gp120 protein-induced intestinal barrier dysfunction by inhibiting the activation of the ERK1/2 signaling pathway in a Caco-2 cell model

open access: yesAIDS Research and Therapy
Background People living with HIV (PLWH) frequently experience non-AIDS comorbidities, driven in part by persistent intestinal barrier dysfunction and systemic inflammation.
Lijiao Zhu   +6 more
doaj   +1 more source

HIV-1 gp120 mannoses induce immunosuppressive responses from dendritic cells.

open access: yesPLoS Pathogens, 2007
The human immunodeficiency virus type 1 (HIV-1) envelope glycoprotein gp120 is a vaccine immunogen that can signal via several cell surface receptors.
Meimei Shan   +10 more
doaj   +1 more source

Highly efficient production of HIV-1AD8 gp120 in mammalian cells

open access: yesJournal of Virology
Human immunodeficiency virus type 1 (HIV-1) envelope glycoproteins (Envs) interact with the CD4 receptor and CCR5/CXCR4 coreceptor expressed on target cells to mediate viral entry. Infection is initiated when the HIV-1 gp120 subunit of Envs binds to host
Tanvi Mathur   +3 more
doaj   +1 more source

Atomic force microscopy fishing and mass spectrometry identification of gp120 on immobilized aptamers

open access: yesInternational Journal of Nanomedicine, 2014
Yuri D Ivanov,1 Natalia S Bukharina,1 Tatyana O Pleshakova,1 Pavel A Frantsuzov,1 Elena Yu Andreeva,1 Anna L Kaysheva,1,2 Victor G Zgoda,1 Alexander A Izotov,1 Tatyana I Pavlova,1 Vadim S Ziborov,1 Sergey P Radko,1 Sergei A Moshkovskii,1 Alexander I ...
Ivanov YD   +12 more
doaj  

HIV-1 envelope, integrins and co-receptor use in mucosal transmission of HIV

open access: yesJournal of Translational Medicine, 2010
It is well established that HIV-1 infection typically involves an interaction between the viral envelope protein gp120/41 and the CD4 molecule followed by a second interaction with a chemokine receptor, usually CCR5 or CXCR4.
Cicala Claudia   +2 more
doaj  

Preliminary evaluation of KYNA ameliorates neuronal pyroptosis induced by HIV-1 gp120

open access: yesInternational Journal of Infectious Diseases
Backgrounds: HIV-associated neurocognitive disorders (HAND) are the common complications in the central nervous system (CNS), mainly causing HIV dementia and leading to serious social economic load.
Dr Xuefeng Gao   +5 more
doaj   +1 more source

Home - About - Disclaimer - Privacy